Condyloma diagnosis, coding, and clinical documentation information for healthcare professionals. Learn about anogenital warts, venereal warts, HPV warts, and their associated ICD-10 codes. Find resources for accurate condyloma identification, treatment, and patient care. This comprehensive guide covers all aspects of condyloma from a medical perspective, including symptoms, causes, and prevention.
Small, fleshy growths caused by human papillomavirus (HPV) infection.
Single or multiple warts in genital or anal areas. Can be raised, flat, or cauliflower-shaped. May be itchy or painful.
Sexual health clinics, dermatology offices, primary care settings.
Complete code families applicable to A63.0
| Description | When to use |
|---|---|
| Genital warts caused by HPV. | Visible genital warts. Confirm with biopsy if needed. HPV DNA test may be helpful. |
| Cervical cell changes caused by HPV. | Abnormal Pap smear. Use for CIN1, CIN2, CIN3. Colposcopy recommended. |
| Anal cell changes caused by HPV. | Abnormal anal Pap smear. Use for AIN1, AIN2, AIN3. Anoscopy recommended. |
Lack of specific HPV type documented may lead to inaccurate coding and affect quality reporting.
Imprecise documentation of the anatomical location (e.g., cervix, anus) can cause coding errors and claim denials.
Insufficient documentation to distinguish condyloma from similar lesions can lead to incorrect diagnosis and coding.
Confirm visual diagnosis: fleshy, papular lesions
Document lesion location, size, morphology
HPV testing considered, type not always necessary
Rule out other STIs, esp if atypical presentation
Patient education: transmission, treatment, recurrence
Patient presents with complaints consistent with anogenital warts, also known as condyloma or venereal warts. Physical examination reveals characteristic flesh-colored to grayish-white papules or plaques in the anogenital region. Lesions are described as exophytic, cauliflower-like, or flat. Patient reports (insert symptom if present, e.g., pruritus, discomfort, bleeding) associated with the lesions. Differential diagnosis includes molluscum contagiosum, seborrheic keratosis, and squamous cell carcinoma. HPV testing (specify type if performed) may be indicated. Diagnosis of condyloma is made based on clinical presentation. Treatment plan includes (specify treatment, e.g., topical imiquimod, cryotherapy, surgical excision) and patient education regarding HPV transmission, safe sex practices, and the potential for recurrence. Follow-up is scheduled for (specify timeframe) to monitor treatment response and assess for any complications such as scarring or infection. ICD-10 code A63.0 (Anogenital (venereal) warts) is assigned. Procedure codes (if applicable, e.g., for cryotherapy or excision) will be documented separately. Patient counseling regarding vaccination against HPV (Gardasil 9) was provided.
Differentiating Condyloma (Anogenital Warts) from other lesions like molluscum contagiosum, seborrheic keratosis, or even squamous cell carcinoma requires a multifaceted approach. Visual inspection focusing on morphology (e.g., verrucous or papillomatous appearance for Condyloma) is crucial. Acetowhitening after application of 3-5% acetic acid can highlight subclinical lesions, particularly helpful for Condyloma. However, biopsy and histopathological examination remain the gold standard for definitive diagnosis, especially when features are atypical or there is suspicion of malignancy. High-resolution anoscopy or colposcopy may be indicated for enhanced visualization and targeted biopsies. Consider implementing a standardized algorithm incorporating these diagnostic modalities for optimal patient management. Explore how HPV DNA testing can be used in conjunction with other methods to improve diagnostic accuracy in challenging cases.
Managing Condyloma in pregnant patients requires careful consideration of treatment modalities due to potential fetal risks. Topical treatments like trichloroacetic acid (TCA) or podophyllin are often preferred during pregnancy, but podophyllin resin is generally contraindicated. Surgical removal methods such as cryotherapy, electrocautery, or laser ablation can be used if topical treatments are ineffective but require careful application to minimize tissue damage. Imiquimod is typically avoided during pregnancy due to limited safety data. It's crucial to counsel pregnant patients about the potential for spontaneous regression of Condyloma postpartum. Learn more about the specific treatment guidelines recommended by professional organizations like the American College of Obstetricians and Gynecologists (ACOG) for evidence-based management strategies.
For recalcitrant Condyloma unresponsive to conventional topical treatments, several advanced therapeutic options exist. Intralesional interferon injections can be effective, particularly for extensive or difficult-to-treat lesions. Laser ablation, while more resource-intensive, offers precise removal with minimal scarring. Surgical excision remains an option for large, resistant warts. The choice of therapy depends on lesion size, location, patient preference, and access to specialized equipment. Explore how combination therapies using different modalities can be tailored for individual cases to optimize efficacy. Consider implementing a staged approach, beginning with less invasive options and escalating to more aggressive interventions as needed based on treatment response.
Clinical accuracy: This information is provided for documentation and coding guidance and should not replace professional medical judgment.
Coding standard: ICD-10-CM, current FY guidelines.